CRTO Criteo posts slight Q4 2025 revenue growth and misses consensus EPS estimates shares tick higher Regeneron Pharmaceuticals REGN NearTerm Margin Pressures Mount Following White House MFN Pricing Agreement and Free Otarmeni Access Pledge Vanguard SP 500 ETF VOO Vestand VSTD Stock Opportunities and Threats Surges Ahead 20260420 Amylyx AMLX Stock Stop Limit Order 324 20260420